High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer
The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC. Expression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohist...
Saved in:
Published in | Frontiers in oncology Vol. 11; p. 740120 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
17.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC.
Expression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function
. Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis.
ATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients (
< 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells
, while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells.
These findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC. |
---|---|
AbstractList | The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC.BACKGROUNDThe role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC.Expression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function in vitro. Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis.METHODSExpression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function in vitro. Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis.ATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients (p < 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells in vitro, while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells.RESULTSATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients (p < 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells in vitro, while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells.These findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC.CONCLUSIONThese findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC. The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC. Expression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function . Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis. ATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients ( < 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells , while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells. These findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC. BackgroundThe role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC.MethodsExpression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function in vitro. Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis.ResultsATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients (p < 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells in vitro, while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells.ConclusionThese findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC. |
Author | Li, Yongxiang Wu, Youliang Wang, Mingliang Xu, Xin Wang, Huizhen Lu, Yida |
AuthorAffiliation | General Surgery Department, The First Affiliated Hospital of Anhui Medical University , Hefei , China |
AuthorAffiliation_xml | – name: General Surgery Department, The First Affiliated Hospital of Anhui Medical University , Hefei , China |
Author_xml | – sequence: 1 givenname: Mingliang surname: Wang fullname: Wang, Mingliang – sequence: 2 givenname: Yida surname: Lu fullname: Lu, Yida – sequence: 3 givenname: Huizhen surname: Wang fullname: Wang, Huizhen – sequence: 4 givenname: Youliang surname: Wu fullname: Wu, Youliang – sequence: 5 givenname: Xin surname: Xu fullname: Xu, Xin – sequence: 6 givenname: Yongxiang surname: Li fullname: Li, Yongxiang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34976799$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kktvEzEUhS1UREvpnhXykkUT_BqP7wZpFPURqRVdFMHO8ng8E1cTO9hORf89E9JWLRLe2Lo-5zuLe96jgxCDQ-gjJXPOFXzpY7BzRhid14JQRt6gI8a4mIHgPw9evA_RSc53ZDqyIpTwd-iQC6hlDXCEwqUfVri5PRf47PcmuZx9DHiZcZNztN4U1-EfvqzwTYwJ36Q4hJh9PsXN2oeIG-s7fO2KaePo8_oUm9DhZlviZmWGB-wDvjC5JG_xwgTr0gf0tjdjdieP9zH6fn52u7icXX27WC6aq5kVkpVZy2jf8gqMUJJXDCrHhHDCCAO9MQAt4z3wjlPHVKcYIcxWFeuJ6l0PrbP8GC333C6aO71Jfm3Sg47G67-DmAZtUvF2dFp1jNasVsAqJVQvFQCtOEgCDgST1cT6umdttu3addaFksz4Cvr6J_iVHuK9VjVVEmACfH4EpPhr63LRa5-tG0cTXNxmzSSVTAkAMkk_vcx6Dnla2CSQe4FNMefkem19MWVa2hTtR02J3pVD78qhd-XQ-3JMRvKP8Yn9X8sfH4q7UA |
CitedBy_id | crossref_primary_10_1038_s41598_024_63895_y crossref_primary_10_3390_metabo13050656 crossref_primary_10_1080_21655979_2022_2066759 crossref_primary_10_2174_0113894501328461240921062056 crossref_primary_10_1016_j_oor_2025_100735 crossref_primary_10_1158_2159_8290_CD_22_1230 crossref_primary_10_3390_ijms231810564 crossref_primary_10_1038_s41598_024_80027_8 crossref_primary_10_1016_j_bbcan_2023_189062 crossref_primary_10_1097_CEJ_0000000000000817 crossref_primary_10_1016_j_actbio_2024_05_033 crossref_primary_10_1111_febs_16992 crossref_primary_10_1186_s12935_024_03279_4 crossref_primary_10_3389_fonc_2023_1218989 crossref_primary_10_3390_cancers15051429 crossref_primary_10_3389_fnmol_2023_1112253 crossref_primary_10_3390_cimb46080519 crossref_primary_10_1016_j_phrs_2024_107355 crossref_primary_10_1016_j_cellsig_2024_111309 crossref_primary_10_1038_s41419_024_07049_y crossref_primary_10_3390_cancers15092661 crossref_primary_10_1007_s12032_022_01879_6 crossref_primary_10_1038_s41417_023_00653_8 crossref_primary_10_1186_s10020_024_01062_9 crossref_primary_10_1016_j_jddst_2024_105998 crossref_primary_10_1016_j_molcel_2024_04_016 |
Cites_doi | 10.1093/bioinformatics/bty271 10.1016/j.biopha.2019.109118 10.1080/15548627.2019.1606647 10.3390/cells8121510 10.1016/j.ccell.2017.12.003 10.3322/caac.21492 10.1093/nar/gkv1070 10.1016/j.celrep.2018.04.032 10.3748/wjg.v22.i8.2403 10.1111/jcmm.15736 10.3892/ijmm.2017.2985 10.1073/pnas.84.23.8355 10.1002/cbin.10760 10.3389/fendo.2020.00556 10.1016/j.jri.2020.103120 10.1172/JCI39366 10.1038/onc.2017.376 10.1158/1078-0432.CCR-17-3125 10.1016/j.molcel.2020.05.007 10.1042/EBC20170027 10.3390/ijms22115566 10.1245/s10434-010-0985-4 10.1172/JCI78031 10.1093/annonc/mdy502 10.1186/s12885-021-08143-6 10.1517/14728222.2012.728207 10.1016/j.cmet.2017.09.001 10.1038/s41418-020-00688-6 10.1038/s41556-019-0347-9 10.1001/jamaoncol.2018.0013 10.7554/eLife.63326 10.1016/j.lfs.2020.117277 10.1158/0008-5472.CAN-20-3694 10.3389/fcell.2020.00177 10.1080/15384101.2016.1151581 10.1016/S1470-2045(18)30739-3 10.1186/1476-4598-13-225 10.1093/jn/nxz309 10.1271/bbb.110990 10.1158/0008-5472 10.1210/jc.2016-2878 10.3389/fonc.2021.654940 10.7150/ijms.43167 10.1371/journal.pone.0031431 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li. Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li 2021 Wang, Lu, Wang, Wu, Xu and Li |
Copyright_xml | – notice: Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li. – notice: Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li 2021 Wang, Lu, Wang, Wu, Xu and Li |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fonc.2021.740120 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2234-943X |
ExternalDocumentID | oai_doaj_org_article_8d217278925848f68991539609e94265 PMC8718699 34976799 10_3389_fonc_2021_740120 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EJD EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-b21fb359a48635295e244e4a4a9faa99b23f93d31e28d82002c552f08fef9bec3 |
IEDL.DBID | M48 |
ISSN | 2234-943X |
IngestDate | Wed Aug 27 01:31:05 EDT 2025 Thu Aug 21 18:31:54 EDT 2025 Fri Jul 11 08:10:12 EDT 2025 Thu Apr 03 06:52:37 EDT 2025 Tue Jul 01 02:46:15 EDT 2025 Thu Apr 24 23:09:09 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | metabolism autophagy nomogram gastric cancer ATF4 activating transcription factor 4 |
Language | English |
License | Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-b21fb359a48635295e244e4a4a9faa99b23f93d31e28d82002c552f08fef9bec3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ORCID: Yongxiang Li, orcid.org/0000-0001-7183-9485; Mingliang Wang, orcid.org/0000-0002-4830-9467 This article was submitted to Gastrointestinal Cancers: Gastric & Esophageal Cancers, a section of the journal Frontiers in Oncology Reviewed by: Souvik Dey, Manipal Academy of Higher Education (MAHE), India; Dean Craig Singleton, The University of Auckland, New Zealand Edited by: Yumin Li, Lanzhou University, China |
OpenAccessLink | https://doaj.org/article/8d217278925848f68991539609e94265 |
PMID | 34976799 |
PQID | 2616284990 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8d217278925848f68991539609e94265 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8718699 proquest_miscellaneous_2616284990 pubmed_primary_34976799 crossref_citationtrail_10_3389_fonc_2021_740120 crossref_primary_10_3389_fonc_2021_740120 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-12-17 |
PublicationDateYYYYMMDD | 2021-12-17 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-17 day: 17 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in oncology |
PublicationTitleAlternate | Front Oncol |
PublicationYear | 2021 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Lee (B6) 1987; 84 Singleton (B17) 2012; 16 Powers (B26) 2018; 34 Sun (B27) 2020; 125 Zhang (B31) 2020; 24 Liu (B10) 2020; 139 Shitara (B3) 2018; 19 Muro (B2) 2019; 30 Gwinn (B41) 2018; 33 Du (B37) 2021; 18 Yoshizawa (B13) 2009; 119 Li (B8) 2017; 41 Horiguchi (B19) 2012; 72 Ligasová (B22) 2019; 8 Torrence (B15) 2021; 10 Alsterda (B34) 2021; 11 Wu (B40) 2017; 40 Tameire (B18) 2019; 21 Dey (B20) 2015; 125 Rabanal-Ruiz (B30) 2017; 61 Yang (B12) 2018; 23 Jiao (B28) 2020; 8 Yang (B42) 2020; 16 Fuchs (B4) 2018; 4 Bray (B1) 2018; 68 Sun (B23) 2014; 13 Wu (B24) 2021; 21 Martinez (B36) 2021; 81 González-González (B38) 2018; 24 Linares (B11) 2017; 26 Qu (B35) 2021; 22 He (B43) 2020; 79 Xu (B14) 2020; 150 Zhu (B44) 2012; 7 Edge (B21) 2010; 17 Bagheri-Yarmand (B39) 2017; 102 Demmings (B7) 2021; 28 Li (B32) 2020; 243 Ku (B9) 2020; 11 Tsuji-Naito (B29) 2012; 76 Kanehisa (B25) 2016; 44 Heydt (B16) 2018; 37 Qin (B33) 2016; 15 Digklia (B5) 2016; 22 |
References_xml | – volume: 34 start-page: I 555 year: 2018 ident: B26 article-title: GSEA-InContext: Identifying Novel and Common Patterns in Expression Experiments publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty271 – volume: 125 year: 2020 ident: B27 article-title: Magnoflorine Inhibits Human Gastric Cancer Progression by Inducing Autophagy, Apoptosis and Cell Cycle Arrest by JNK Activation Regulated by ROS publication-title: BioMed Pharmacother doi: 10.1016/j.biopha.2019.109118 – volume: 16 year: 2020 ident: B42 article-title: MTORC1 Coordinates the Autophagy and Apoptosis Signaling in Articular Chondrocytes in Osteoarthritic Temporomandibular Joint publication-title: Autophagy doi: 10.1080/15548627.2019.1606647 – volume: 8 start-page: 1510 year: 2019 ident: B22 article-title: A New Sensitive Method for the Detection of Mycoplasmas Using Fluorescence Microscopy publication-title: Cells doi: 10.3390/cells8121510 – volume: 33 start-page: 91 year: 2018 ident: B41 article-title: Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase publication-title: Cancer Cell doi: 10.1016/j.ccell.2017.12.003 – volume: 68 start-page: 394 year: 2018 ident: B1 article-title: Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21492 – volume: 44 year: 2016 ident: B25 article-title: KEGG as a Reference Resource for Gene and Protein Annotation publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv1070 – volume: 23 year: 2018 ident: B12 article-title: ATF4 Regulates CD4+ T Cell Immune Responses Through Metabolic Reprogramming publication-title: Cell Rep doi: 10.1016/j.celrep.2018.04.032 – volume: 22 year: 2016 ident: B5 article-title: Advanced Gastric Cancer: Current Treatment Landscape and Future Perspectives publication-title: World J Gastroenterol doi: 10.3748/wjg.v22.i8.2403 – volume: 24 year: 2020 ident: B31 article-title: M6a Methyltransferase METTL3 Promotes Retinoblastoma Progression via PI3K/AKT/mTOR Pathway publication-title: J Cell Mol Med doi: 10.1111/jcmm.15736 – volume: 40 year: 2017 ident: B40 article-title: Silencing of Both ATF4 and PERK Inhibits Cell Cycle Progression and Promotes the Apoptosis of Differentiating Chondrocytes publication-title: Int J Mol Med doi: 10.3892/ijmm.2017.2985 – volume: 84 year: 1987 ident: B6 article-title: A Cellular Protein, Activating Transcription Factor, Activates Transcription of Multiple E1A-Inducible Adenovirus Early Promoters publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.84.23.8355 – volume: 41 start-page: 599 year: 2017 ident: B8 article-title: Silencing of ATF2 Inhibits Growth of Pancreatic Cancer Cells and Enhances Sensitivity to Chemotherapy publication-title: Cell Biol Int doi: 10.1002/cbin.10760 – volume: 11 year: 2020 ident: B9 article-title: Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2020.00556 – volume: 139 year: 2020 ident: B10 article-title: Activating Transcription Factor 6 Regulated Cell Growth, Migration and Inhibiteds Cell Apoptosis and Autophagy via MAPK Pathway in Cervical Cancer publication-title: J Reprod Immunol doi: 10.1016/j.jri.2020.103120 – volume: 119 year: 2009 ident: B13 article-title: The Transcription Factor ATF4 Regulates Glucose Metabolism in Mice Through Its Expression in Osteoblasts publication-title: J Clin Invest doi: 10.1172/JCI39366 – volume: 37 year: 2018 ident: B16 article-title: Oncogenic FLT3-ITD Supports Autophagy via ATF4 in Acute Myeloid Leukemia publication-title: Oncogene doi: 10.1038/onc.2017.376 – volume: 24 year: 2018 ident: B38 article-title: Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-3125 – volume: 79 start-page: 30 year: 2020 ident: B43 article-title: Acetyl-CoA Derived From Hepatic Peroxisomal β-Oxidation Inhibits Autophagy and Promotes Steatosis via mTORC1 Activation publication-title: Mol Cell doi: 10.1016/j.molcel.2020.05.007 – volume: 61 year: 2017 ident: B30 article-title: mTORC1 as the Main Gateway to Autophagy publication-title: Essays Biochem doi: 10.1042/EBC20170027 – volume: 22 year: 2021 ident: B35 article-title: Autophagy Induction by Trichodermic Acid Attenuates Endoplasmic Reticulum Stress-Mediated Apoptosis in Colon Cancer Cells publication-title: Int J Mol Sci doi: 10.3390/ijms22115566 – volume: 17 year: 2010 ident: B21 article-title: The American Joint Committee on Cancer: The 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-0985-4 – volume: 125 year: 2015 ident: B20 article-title: ATF4-Dependent Induction of Heme Oxygenase 1 Prevents Anoikis and Promotes Metastasis publication-title: J Clin Invest doi: 10.1172/JCI78031 – volume: 30 start-page: 19 year: 2019 ident: B2 article-title: Pan-Asian Adapted ESMO Clinical Practice Guidelines for the Management of Patients With Metastatic Gastric Cancer: A JSMO-ESMO Initiative Endorsed by CSCO, KSMO, MOS, SSO and TOS publication-title: Ann Oncol doi: 10.1093/annonc/mdy502 – volume: 21 start-page: 433 year: 2021 ident: B24 article-title: Expression and Functional Characterization of INPP4B in Gallbladder Cancer Patients and Gallbladder Cancer Cells publication-title: BMC Cancer doi: 10.1186/s12885-021-08143-6 – volume: 16 year: 2012 ident: B17 article-title: Targeting the ATF4 Pathway in Cancer Therapy publication-title: Expert Opin Ther Targets doi: 10.1517/14728222.2012.728207 – volume: 26 start-page: 817 year: 2017 ident: B11 article-title: ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the P62-Deficient Tumor Stroma publication-title: Cell Metab doi: 10.1016/j.cmet.2017.09.001 – volume: 28 year: 2021 ident: B7 article-title: Activating Transcription Factor-4 Promotes Neuronal Death Induced by Parkinson's Disease Neurotoxins and α-Synuclein Aggregates publication-title: Cell Death Differ doi: 10.1038/s41418-020-00688-6 – volume: 21 year: 2019 ident: B18 article-title: ATF4 Couples MYC-Dependent Translational Activity to Bioenergetic Demands During Tumour Progression publication-title: Nat Cell Biol doi: 10.1038/s41556-019-0347-9 – volume: 4 start-page: e180013 year: 2018 ident: B4 article-title: Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2018.0013 – volume: 10 start-page: e63326 year: 2021 ident: B15 article-title: The mTORC1-Mediated Activation of ATF4 Promotes Protein and Glutathione Synthesis Downstream of Growth Signals publication-title: Elife doi: 10.7554/eLife.63326 – volume: 243 year: 2020 ident: B32 article-title: Berberine Mitigates High Glucose-Induced Podocyte Apoptosis by Modulating Autophagy via the mTOR/P70S6K/4EBP1 Pathway publication-title: Life Sci doi: 10.1016/j.lfs.2020.117277 – volume: 81 year: 2021 ident: B36 article-title: SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-20-3694 – volume: 8 year: 2020 ident: B28 article-title: Adipose-Derived Stem Cells Protect Ischemia-Reperfusion and Partial Hepatectomy by Attenuating Endoplasmic Reticulum Stress publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2020.00177 – volume: 15 year: 2016 ident: B33 article-title: 4e-BP1, A Multifactor Regulated Multifunctional Protein publication-title: Cell Cycle doi: 10.1080/15384101.2016.1151581 – volume: 19 year: 2018 ident: B3 article-title: Trifluridine/tipiracil Versus Placebo in Patients With Heavily Pretreated Metastatic Gastric Cancer (TAGS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(18)30739-3 – volume: 13 year: 2014 ident: B23 article-title: Down Regulation of Thrombospondin2 Predicts Poor Prognosis in Patients With Gastric Cancer publication-title: Mol Cancer doi: 10.1186/1476-4598-13-225 – volume: 150 year: 2020 ident: B14 article-title: ATF4-Mediated Upregulation of REDD1 and Sestrin2 Suppresses mTORC1 Activity During Prolonged Leucine Deprivation publication-title: J Nutr doi: 10.1093/jn/nxz309 – volume: 76 year: 2012 ident: B29 article-title: Concentrated Bovine Milk Whey Active Proteins Facilitate Osteogenesis Through Activation of the JNK-ATF4 Pathway publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.110990 – volume: 72 start-page: 395 year: 2012 ident: B19 article-title: Stress-Regulated Transcription Factor ATF4 Promotes Neoplastic Transformation by Suppressing Expression of the INK4a/ARF Cell Senescence Factors publication-title: Cancer Res doi: 10.1158/0008-5472 – volume: 102 year: 2017 ident: B39 article-title: ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2016-2878 – volume: 11 year: 2021 ident: B34 article-title: Salubrinal Exposes Anticancer Properties in Inflammatory Breast Cancer Cells by Manipulating the Endoplasmic Reticulum Stress Pathway publication-title: Front Oncol doi: 10.3389/fonc.2021.654940 – volume: 18 year: 2021 ident: B37 article-title: ATF4 Promotes Lung Cancer Cell Proliferation and Invasion Partially Through Regulating Wnt/β-Catenin Signaling publication-title: Int J Med Sci doi: 10.7150/ijms.43167 – volume: 7 start-page: e31431 year: 2012 ident: B44 article-title: Activating Transcription Factor 4 Confers a Multidrug Resistance Phenotype to Gastric Cancer Cells Through Transactivation of SIRT1 Expression publication-title: PloS One doi: 10.1371/journal.pone.0031431 |
SSID | ssj0000650103 |
Score | 2.416794 |
Snippet | The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the... BackgroundThe role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 740120 |
SubjectTerms | activating transcription factor 4 ATF4 autophagy gastric cancer metabolism nomogram Oncology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhh5JLaZu0ddIUFXIJxN2sLcnS0Q3ZpIUNOSQ0NyHr0RgSOex6of33mbG9y24p7aVXP7CYh78ZZvg-Qo5yYQRAgYVM4zxlwsvUCFukgfuqUtk4VA4nutMrcXnLvt3xuzWpL9wJ6-mBe8ONpEMJpUKqDKBSBgH9ASQp8qR5BejSsZcC5q01U_0_mKOAQT-XhC5MjUITkbEwG39GDTqU917DoY6u_0815u-rkmvYM3lFXg5FIy37w74mWz6-IS-mw1h8l0Tc1qDlzYTR85_DZmukX-d0aXzv6Pe6vafXTTOj17MGt-vq-QktH-vY0NLWjk59C_HwUM8fT6iJjpYLpBwwP37ROtILg_Ielp5hjMz2yO3k_ObsMh2EFFLLRNamFdo858owCfVFprgHUPfMMKOCMUpVWR5U7vKxz6STuLZhOc_CqQw-KHBy_pZsxyb694Qi5ZQ3ooDMtcxV0JcLw5wNIfenzAuekNHSrNoOLOModvGgodtAR2h0hEZH6N4RCTlevfHUM2z85dkv6KnVc8iN3V2AiNFDxOh_RUxCPi39rCGXcEBiom8Wcw3dpAC4BoBOyLve76tP5QwKt0KphBQbEbFxls07sb7v-LqhJ5VCqf3_cfgDsoP2wIWacfGBbLezhT-EsqitPnYZ8AxOUAaI priority: 102 providerName: Directory of Open Access Journals |
Title | High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34976799 https://www.proquest.com/docview/2616284990 https://pubmed.ncbi.nlm.nih.gov/PMC8718699 https://doaj.org/article/8d217278925848f68991539609e94265 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBYlhdJLadPXJm1QoZdCnMR62TqE4IZs0sKWHLJ0b0a2pcSwkRvbC8m_74zt3WbLUnrxwZYtWd-MZsYaf0PIZ66MAlOQg6ZJGQhl48CoPAqctFmmWeiyAnd0Jz_UxVR8n8nZn9-jhwlsNoZ2WE9qWs8P7u8eTkDhjzHiBHt76CqPZIQsPMDycgwC-KdglyJU08ng7PfrssSiBlhtjnERaMFn_b7lxoes2amOzn-TD_p3KuUj2zR-SV4MTiVNeil4RZ5Yv02eTYZt89fEYzYHTa7Ggp7dD5mvnn5r6BIcW9CfZXtDL6uqppd1hdl3ZbNPk9vSVzTJy4JObAvyMi-b231qfEGTBVISmOsHWnp6brD8R05PUYbqN2Q6Prs6vQiGQgtBLhRrgwwx4VIbEYP_wbS0YPStMMJoZ4zWGeNO84KHlsVFjGkduZTMHcXOOg1CwN-SLV95-55QpKSyRkWg2bkoMojblRFF7hy3R8IqOSKHy2lN84GFHIthzFOIRhCIFIFIEYi0B2JEvqzu-NUzcPyj7VdEatUOubO7E1V9nQ6qmMYFFuWKYs3A-YqdgogTln1k3rMa_BUY4qclzinoGm6gGG-rRZNCtKnAnIMBH5F3Pe6rrrgAxy7SekSiNYlYG8v6FV_edHzeELPGSuud_-h3lzzH18V8mjD6QLbaemE_glfUZnvd1wQ4ns_CvU7wfwOZcQpE |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+ATF4+Expression+Is+Associated+With+Poor+Prognosis%2C+Amino+Acid+Metabolism%2C+and+Autophagy+in+Gastric+Cancer&rft.jtitle=Frontiers+in+oncology&rft.au=Wang%2C+Mingliang&rft.au=Lu%2C+Yida&rft.au=Wang%2C+Huizhen&rft.au=Wu%2C+Youliang&rft.date=2021-12-17&rft.issn=2234-943X&rft.eissn=2234-943X&rft.volume=11&rft.spage=740120&rft_id=info:doi/10.3389%2Ffonc.2021.740120&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon |